Psychotropics use in the Spanish elderly: Predictors and evolution between years 1993 and 2003

Pharmacoepidemiology and Drug Safety

Volumn 16, Issue 4, 2007, Pages 449-457

  Carrasco Garrido, Pilar ^a   Jimenez Garcia R ^a   Astasio Arbiza, P ^b   Ortega Molina, P ^b   Gil de Miguel, A ^a  

^a UNIVERSIDAD REY JUAN CARLOS   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Elderly; Prevalence; Psychoactive drugs; Sex

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; HYPNOTIC AGENT; PSYCHOTROPIC AGENT;

AGED; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DRUG USE; EPIDEMIOLOGICAL DATA; FEMALE; HEALTH BEHAVIOR; HEALTH SURVEY; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEUROLOGIC DISEASE; PREDICTION; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; SELF MEDICATION; SEX DIFFERENCE; SLEEP DISORDER; SOCIAL ASPECT; SPAIN;

AGED; CROSS-SECTIONAL STUDIES; DRUG UTILIZATION; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; LOGISTIC MODELS; MALE; ODDS RATIO; PRESCRIPTIONS, DRUG; PSYCHOTROPIC DRUGS; QUESTIONNAIRES; SEX FACTORS; SPAIN; TIME FACTORS;

EID: 34247485507     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1344     Document Type: Article

References (61)

1. AENOR. Certification and normalization. Healthy sector 2002. AENOR informs.
2. IMSERSO. Envejecer en España. IIa Asamblea Mundial del envejecimiento. IMSERSO: Madrid, 2002.
3. Valderrama Gama E, Rodriguez Artalejo F, Palacios Diaz A, Gabarre Orus P, Perez del Molino Martin J. Drug consumption by the elderly: results of population studies. Rev Esp Salud Publica 1998; 72 (3): 209-219.
4. Pedrera Zamorano JD, Canal Macias ML, Lavado Garcia JM, Postigo Mota S, Sanchez Belda, M, Duran Gomez N. A health study of older persons in Extremadura: drug taking and the most frequent chronic diseases. Rev Esp Salud Pública 1999; 73 (6): 677-686.
5. Lemfelt B, Samuelsson O, Skoog I, Landahl S. Changes in drug treatment in the elderly between 1971 and 2000. Eur J Clin Pharmacol 2003; 59 (8-9): 637-644.
6. Lopez-Torres Hidalgo J, Cerda Diaz R, Fernandez Olano C, Requena Gallego M, Fernandez Casalderrey C, Otero Puime A. Factors associated with chronic drug consi ption in the elderly. Med Clin (Barc) 1997; 108 (15): 572-576.
7. Fulton M, Riley Allen E. Polypharmacy in the elderly: a literature review. J Am Acad Nurse Pract 2005; 17 (4): 123-132.
8. Laurier C, Moride Y, Kennedy WA. Health survey data on potentially inappropriate geriatric drug use. Ann Pharmacother 2002; 36 (3): 404-409.
9. Fialova D, Topinkova. E, Gambassi G, et al. AdHOC Project Research Group. Potentially inappropriate medication use among elderly home care patients in Europe. JAMA 2005; 293 (11): 1348-1358.
10. Linjakumpu T, Hanikainen S, Klaukka T, Veijola J, Kivela SL, Isoaho R. Use of medications and polypharmacy are increasing among the elderly. J Clin Epidemiol 2002; 55 (8): 809-817.
11. Paulose-Ram R, Jonas BS, Orwig D, Safran MA. Prescription psychotropic medication use among the U.S. adult population: results from the third National Health and Nutrition Examination Survey, 1988-1994. J Clin Epidemiol 2004; 57 (3): 309-317.
12. Verger P, Aulagnier M, Protopopescu C, et al. Hypnotic and tranquillizer use among general practitioners in south-eastern France and its relation to occupational characteristics and prescribing habits. Fundam Clin Pharmacol 2004; 18 (3): 379-385.
13. Vilena Ferrer A, Tellez Lapeira JM, Morena Rayo S, Donato Gallart E, Almar Marques E. Consumption of psychodrugs. Influence of family dysfunction. Actas Esp Psiquiatr 2004; 32 (3): 143-148.
14. Voyer P, Cohen D, Lauzon S, Collin J. Factors associated with psychotropic drug use among community-dwelling older persons: a review of empirical studies. BMC Nurs 2004 13; 3 (1): 3.
15. Empereur F, Baumann M, Alla F, Briancon S. Factors associated with the consumption of psychotropic drugs in a cohort of men and women aged 50 and over. J Clin Pharm Ther 2003; 28 (1): 61-68.
16. Ohayon MM, Lader MH. Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom. J Clin Psychiatry 2002; 63 (9): 817-825.
17. Alonso J, Angermeyer MC, Bernet S, et al. Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl 2004; (420): 55-64.
18. Kisely S, Linden M, Bellantuono C, Simon G, Jones J. Why are patients prescribed psychotropic drugs by general practitioners? Results of an international study. Psychol Med 2000; 30 (5): 1217-1225.
19. Mort JR, Aparasu RR. Prescribing potentially inappropriate psychotropic medications to the ambulatory elderly. Arch Intern Med 2000; 160 (18): 2825-2831.
20. Mort JR, Aparasu RR. Prescribing of psychotropics in the elderly: why is it so often inappropriate? CNS Drugs 2002; 16 (2): 99-109.
21. Van Dijk KN, de Vries CS, ter Huurne K, van den Berg PB, Bronwers JR, de Jong-van den Berg LT. Concomitant prescribing of benzodiazepines during antidepressant therapy in the elderly. J Clin Epidemiol 2002; 55 (10): 1049-1053.
22. Lechevallier N, Fourrier A, Bert C. Benzodiazepine use in the elderly. The EVA Study. Rev Epidemiol Sante Publique 2003; 51: 317-323.
23. Ayuso-Mateos JL, et al. Depressive disorders in Europe: prevalence figures from the ODIN study. Br J Psychiatry 2001; 179: 308-316.
24. Ústün TB, Ayuso-Mateos JL, Chatterji S, Mathers C, Muria CJL. Global burden of depressive disorder in the year 2000. Br J Psychiatry 2004; 184: 386-392.
25. Copeland JR, et al. Depression in Europe. Geographical distribution among older people. Br J Psychiatry 1999; 174: 312-321.
26. Biderman A, Cwikel J, Fried AV, Galinsky D. Depression and falls among community dwelling elderly people: a search for common risk factors. J Epidemiol Community Health 2002; 56: 631-636.
27. Ministerio de Sanidad y Consumo. Subdirección General de Epidemiología, Promoción y Educación para la Salad. Encuesta Nacional de Salad de España 1993[Spanish Nacional Health Survey 20011. Madrid (Spain), 1995.
28. Ministerio de Sanidad y Consumo. Subdirección General de Epidemiología, Promoción y Educación para la Salud. Encuesta Nacional de Salad de España 2001 [Spanish Nacional Health Survey 2003]. Madrid (Spain), 2005.
29. Laporte JR, Castel JM. El médico ante la automedicación. Med Clin (Barc) 1992; 99: 414-416.
30. Furu K, Straume B. Use of antacids in a general population: the impact of health-related variables, lifestyle and sociodemographic characteristic. J Clin Epidemiol 1999; 52 (6): 509-516.
31. Simoni-Wastila L, Ritter G, Strickler G. Gender and others factors associated with the nonmedical use abusable prescription drugs. Subst Use Misuse 2004; 39 (1): 1-23.
32. Makhlouf Obermeyer C, Schulein M, Kasparian C, Ammar W. Medication use, gender, and socio-economic status in Lebano analysis of national survey. J Med Liban 2002; 50 (5-6): 216-225.
33. Lapeyre-Mestre M, Chastan E, Louis A, Montastruc JL. Drug consumption in workers in France: a comparative study at a 10-year interval (1996 versus 1986). J Clin Epidemiol 1999; 52 (5): 471-478.
34. Del Rio MC, Prada C, Alvarez FJ. The use of medication by the Spanish population. PD Safe 1997; 6 (1): 41-48.
35. Guzmán C, Del Castillo A, Carrasco P, Gil A. Estudio epidemiológico del consumo de medicamentos antihipertensivos a partir de los datos obtenidos en las encuestas nacionales de salud de España de los años 1993, 1995 y 1997. Hipertensión 2004; 19 (5): 206-214.
36. Figueiras A, Caamaño F, Gestal-Otero JJ. Sociodemographics factors related to self-medication in Spain. Eur J Epidemiol 2002; 16 (1): 19-26.
37. Regidor E, Rodríguez C, Gutiérrez-Fisac JL. Indicadores de Salud. Tercera evaluación en España del programa regional europeo de Salad para todos. Ministerio de Sanidad y Consumo Madrid 1995; 47-48.
38. Dealberto MJ, Seeman T, McAvay GJ, Berkman L. Factors related to current and subsequent psychotropic drug use in an elderly cohort. J Clin Epidemiol 1997; 50 (3): 357-364.
39. Hemels ME, Koren G, Einarson TR. Increased use of anti-depressants in Canada: 1981-2000. Ann Pharmacother 2002 Sep; 36 (9): 1375-1379.
40. Aparasu RR, Mort JR. Prevalence, correlates, and associated outcomes of potentially inappropriate psychotropic use in the community-dwelling elderly. Am J Geriatr Pharmacother 2004; 2 (2): 102-111.
41. Hartikainen S, Rahkonen T, Kautiainen H, Sulkava R. Kuopio 75+ study: does advanced age predict more common use of psychotropics among the elderly? Int Clin Psychopharmacol 2003; 18 (3): 163-167.
42. Nielsen MW, Hansen EH, Rasmussen NK. Patterns of psychotropic medicine use and related diseases across educational groups: national cross-sectional survey. Eur J Clin Pharmacol 2004; 60 (3): 199-204.
43. Ohayon MM, Caulet M, Priest RG, Guilleminault C. Psychotropic medication consumption patterns in the UK general population. J Clin Epidemiol 1998; 51 (3): 273-283.
44. Carrasco P, Astasio P, Ortega P, Jimenez R, Gil A. Factors related to psychotropic drugs consumption among die Spanish adult population. Data from the Spanish National Health Surveys for 1993, 1995 and 1997. Med Clin (Barc) 2001 10; 116 (9): 324-329.
45. Carrasco P, Regidor E, Astasio P, Gil A. [Estudio epidemiológico del consumo de psicotropos a partir de los datos obtenidos de la Encuesta Nacional de Salad de España del año 1993]. Medicina Preventiva 1998; 4 (2): 6-14.
46. Simoni-Wastila L. Gender and psychotropic drug use. Med Care 1998; 36 (1): 88-94.
47. Maggini M, Spila S. The prescription of psycho-pharmaceutical in general medicines: gender differences. Epidemiol Prev 1996; 20 (2-3): 261-262.
48. Aparasu R, Mort R, Brandt H. Psychotropic prescription use by community-dwelling elderly in the United Status. J Am Geriatr Soc 2003; 51 (5): 671-677.
49. Simoni-Wastila L. The use of abusable prescription drugs: the role of gender. J Womens Health Gend Based Med 2000; 9 (3): 289-297.
50. Simoni-Wastila L, Ritter G, Strickler G. Gender and others factors associated with the nonmedical use abusable prescription drugs. Subst Use Misuse 2004; 39 (1): 1-23.
51. Ruiz-Cantero MT, Verdú-Delgado M. Gender bias in treatment. Gac San 2004; 18(supl 1): 118-125.
52. Paterniti S, Dufouil C, Alperovitch A. Long-term benzodiazepine use and cognitive decline in the Epidemiology of Vascular Aging Study. J Clin Psychopharmacol 2002; 22 (3): 285-293.
53. Ohayon MM, Lemoine P. Daytime consequences of insomnia complaints in the French general population. Encephale 2004; 30 (3): 222-227.
54. Fourrier A, Letenneur L, Dartigues JF, Moore N, Begaud B. Benzodiazepine use in an elderly community-dwelling population. Characteristic of users and factors associated with subsequent use. Eur J Clin Pharmacol 2001; 57 (5): 419-425.
55. Hartikainen S, Klaukka T. Use of psychotropics is high among very old people. Eur J Clin Pharmacol 2004; 59 (11): 849-850.
56. Mort J, Aparasu R. Prescribing of psychotropics in the elderly: why is it so often inappropriate? CNS Drugs 2002; 16 (2): 99-109.
57. Preville M, Ducharme C, Fortin D, et al. Anxiolytic, sedative and hypnotic medication use in the elderly living in the community: developing a conceptual framework. Sante Ment Que 2003; 28 (2): 165-182.
58. Jeantaud I, Haramburu F, Bégaud B. Benzodiazepine use: survey of community pharmacies in south-western France. Thérapie 2001; 56: 415-419
59. Fourrier A, Letenneur L, Dartigues JF, Moore N, Begaud B. Benzodiazepine use in an elderly community-dwelling population. Characteristic of users and factors associated with subsequent use. Eur J Clin Pharmacol 2001; 57 (5): 419-425.
60. Paterniti S, Dufouil C, Alperovitch A. Long-term benzodiazepine use and cognitive decline in the epidemiology of vascular aging study. J Clin Psychopharmacol 2002; 22 (3): 285-293.
61. Allard J, Artero S, Ritchie K. Consumption of psychotropic medication in the elderly: a re-evaluation of its effect on cognitive performance. Int J Geriatr Psychiatry 2003; 18 (10): 874-878.